Oragenics (OGEN) Assets (2010 - 2026)
Oragenics' (OGEN) quarterly Assets came in at $7.5 million in Q1 2026, up 93.58% YoY from $3.9 million in Q1 2025, and down 25.61% on a QoQ basis from $10.1 million in Q4 2025.
Oragenics (OGEN) Assets (2010 - 2026) Analysis & Trends
Oragenics (OGEN) has 17 years of Assets data on file, last reported at $7.5 million in Q1 2026.
- Quarterly Assets rose 93.58% year-over-year to $7.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.5 million (up 93.58% YoY) and the FY2025 annual result came in at $10.1 million, up 583.71% from the prior year.
- Assets slipped to $7.5 million in Q1 2026, from $10.1 million in the prior quarter.
- In the past five years, Assets ranged from a high of $23.6 million in Q1 2022 to a low of $1.5 million in Q4 2024.
- A 5-year average of $9.3 million and a median of $7.9 million in 2023 frame the typical range for Assets.
- Annual changes were most pronounced in 2024 — Assets sank 70.86% — and 2025, when it soared 583.71%.
- Tracing OGEN's Assets over 5 years: stood at $14.8 million in 2022, then plunged by 66.35% to $5.0 million in 2023, then tumbled by 70.35% to $1.5 million in 2024, then soared by 583.71% to $10.1 million in 2025, then declined by 25.61% to $7.5 million in 2026.
- The last three Assets figures came in at $7.5 million (Q1 2026), $10.1 million (Q4 2025), and $12.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Oragenics | 2.38 Mn | 2.38 Mn | - | 5.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.49 Mn |
| Mar 31, 2026 | 7.49 Mn |
| Dec 31, 2025 | 10.07 Mn |
| Sep 30, 2025 | 12.71 Mn |
| Jun 30, 2025 | 2.14 Mn |
| Mar 31, 2025 | 3.87 Mn |
| Dec 31, 2024 | 1.47 Mn |
| Sep 30, 2024 | 5.20 Mn |
| Jun 30, 2024 | 2.71 Mn |
| Mar 31, 2024 | 3.53 Mn |
| Dec 31, 2023 | 4.97 Mn |
| Sep 30, 2023 | 7.90 Mn |
| Jun 30, 2023 | 8.46 Mn |
| Mar 31, 2023 | 12.13 Mn |
| Dec 31, 2022 | 14.76 Mn |
| Sep 30, 2022 | 17.05 Mn |
| Jun 30, 2022 | 20.35 Mn |
| Mar 31, 2022 | 23.65 Mn |
| Dec 31, 2021 | 28.23 Mn |
| Sep 30, 2021 | 31.09 Mn |